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Background. Transcription factor Cdx4 and transcriptional coregulator menin are essential for Hoxa9 expression and normal
hematopoiesis. However, the precise mechanism underlying Hoxa9 regulation is not clear. Methods and Findings. Here, we
show that the expression level of Hoxa9 is correlated with the location of increased trimethylated histone 3 lysine 4 (H3K4M3).
The active and repressive histone modifications co-exist along the Hoxa9 regulatory region. We further demonstrate that both
Cdx4 and menin bind to the same regulatory region at the Hoxa9 locus in vivo, and co-activate the reporter gene driven by the
Hoxa9 cis-elements that contain Cdx4 binding sites. Ablation of menin abrogates Cdx4 access to the chromatin target and
significantly reduces both active and repressive histone H3 modifications in the Hoxa9 locus. Conclusion. These results
suggest a functional link among Cdx4, menin and histone modifications in Hoxa9 regulation in hematopoietic cells.
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INTRODUCTION
Homeo-box-containing transcription factors (Hox proteins) play
a pivotal role in normal differentiation and expansion of hemato-
poietic cells [1,2]. Overexpression of several Hox genes such as
Hoxa9 induce leukemia reminiscent of mixed lineage leukemia
(MLL) [1]. The MLL gene is frequently targeted by chromosomal
translocations in acute lymphoid and myeloid leukemias (ALL and
AML, respectively) [3], resulting in generation of various MLL-
fusion proteins with the amino portion of MLL fused in frame with
one of over 50 different potential fusion partners. Many MLL
fusion proteins cause dysregulation of Hox genes including Hoxa9.
Both human and murine leukemias triggered by MLL-AF9 are
most frequently myeloid in phenotype [4–6].
Menin was originally identified as a tumor suppressor encoded
by Men1 that is mutated in the human inherited tumor syndrome,
multiple endocrine neoplasia type 1 (MEN1) [7,8]. It interacts with
a variety of transcriptional factors and MLL proteins [9–12].
Recently, we and others have shown that menin regulates
hematopoiesis and myeloid transformation by influencing Hox
gene expression [13,14]. Menin and MLL fusion proteins are
required for persistent expression of 59 Hoxa cluster genes,
including Hoxa5 to Hoxa10 [14]. Despite the advances in
understanding the oncogenic contributions of the menin-MLL
complex, precisely how expression of Hoxa cluster genes is
regulated in hematopoietic cells remains unclear.
The vertebrate Cdx genes (Cdx1, Cdx2 and Cdx4 in the mouse)
encode homeodomain transcription factors related to the Drosophila
caudal genes. They belong to the ParaHox gene family and share
common ancestry with the Hox genes [15]. In zebrafish, a Cdx4
mutant, kgg
tv205, causes an early defect in hematopoiesis and
aberrant expression of multiple Hox genes, particularly Hoxb6b and
Hoxa9a [16]. Ectopic expression of Cdx4 induced a pronounced
expansion of multi-lineage progenitors from differentiating mouse
embryonic stem cells, including an increase in granulocyte-
erythroid-macrophage-megakaryocyte colonies and in granulo-
cyte-macrophage colonies, as compared with control cells [16].
These data indicate that Cdx4 is essential for Hoxa9 regulation in
normal hematopoiesis.
There is substantial data demonstrating an essential role for
Hoxa9 protein in both normal hematopoiesis [17] and leukemic
transformation induced by certain MLL fusion proteins [18].
Hoxa9 overexpression is a common feature of acute myeloid
leukemia [19–21]. Although both menin and Cdx4 have been
shown to participate in regulating Hoxa9 gene transcription and
hematopoiesis, little is known as to whether or how Cdx4 interacts
with the Hoxa9 locus to regulate its expression, and whether menin
and Cdx4 crosstalk to regulate expression of Hoxa cluster genes.
In this study, we used two MLL-AF9 transformed cell lines, AT1
and AR1, as a model system to investigate Hoxa9 regulation. We
showed that histone modifications, especially methylation of histone
H3, play an important role in determining the level of Hoxa9
expression, and menin is crucial for both active and repressive
histone modifications in the Hoxa9 locus. We also demonstrated
a crosstalk between menin and Cdx4 in co-regulating expression of
Hoxa9 gene. These results uncovered a functional link among Cdx4,
menin and histone modifications of histone H3 in maintaining 59
Hoxa cluster transcription, thus providing novel insights into our
understanding of regulation of Hox gene expression.
RESULTS
Distinct levels of Hox gene expression in two MLL-
AF9 transformed cell lines
AT1 and AR1 cell lines were both transformed by transduction of
MLL-AF9 fusion genes, however, compared to AT1, AR1 cells
were cultured easily and grew faster (S Fig. 1A). The expression
levels of Hoxa5, Hoxa7 and Hoxa9 in AR1 cells, as measured by
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PLoS ONE | www.plosone.org 1 December 2006 | Issue 1 | e47qPCR, were 20 to 40 fold higher than those in AT1 cells. The
Hoxa10 level in AR1 cells was even 105 fold higher than in AT1
cells (S Fig. 1B), while the expression of Hoxa1 and Hoxa13 was not
detectable in AT1 cells. These results suggest that expression of
multiple Hox genes in AR1 cells is generally higher than that in
AT1 cells, consistent with a more aggressive phenotype of AR1
cells (S Fig. 1C).
More importantly, the morphology and expression profile of 59
Hoxa cluster genes in AT1 and AR1 cells are strikingly similar to
the previously published two distinct stages of MLL-AF9
transformed hematopoietic cells: preleukemic and leukemic stages
[4,22,23]. In those studies, the authors found that MLL-AF9
fusion induced generation of preleukemic cells followed by overt
leukemic cells [4]. In contrast to leukemic cells, preleukemic cells
possessed a high differentiation potential and expressed a lower
level of 59 Hoxa cluster genes [22,23]. Mouse embryonic fibroblast
(MEF) cells were often used to study histone modifications in
Hoxa9 gene expression [24,25]. The expression level of Hoxa9 in
AT1 cells was only two fold higher than in MEF cells (Fig. 1E).
Apparently AT1 cells have not transformed into overt leukemic
cells but possessed differentiation potential associated with an early
stage of MLL-AF9 transformation, similar to the preleukemic cells
[4]. Therefore, utilization of AR1 and AT1 cell lines would
facilitate our understanding of the altered regulation of Hox genes
in various stages of leukemia.
Multiple functional elements spread over the
regulatory sequence of Hoxa9 gene
Initiation of Hox gene transcription requires interaction among
numerous factors recruited to the target gene, particularly to the
multiple functional elements, so as to establish their precise
domain boundaries in the developing tissue [26]. The Hoxa9
regulatory region may serve as binding sites for various
transcription factors and co-regulators to regulate the magnitude
of Hoxa9 expression. To identify the regulatory elements in the
Hoxa9 gene, we employed a luciferase reporter assay to
quantitatively analyze the cis-elements in the Hoxa9 locus to
regulate its expression. Various cis-elements ranging from 21222
to +1226 of the Hoxa9 locus were inserted upstream of the
luciferase reporter to generate reporters pA through pF (S Fig. 2A).
The effects of each regulatory element on reporter gene activity
were tested in MEFs (S Fig. 2B). Luciferase assays identified
a strong activating element located at 59 promoter region, B, and
two other activating elements within the 59 untranslated region
(59-UTR), E and F. A repressive fragment, as represented by
elements C and D, is located between the two activating elements,
B and E (S Fig. 2B). These results suggest that both positive and
negative regulators are involved in regulating Hoxa9 transcription
through distinct cis-elements in the Hoxa9 locus.
The level of Hoxa9 expression correlates with the
location of the increased lysine 4-trimethylated
histone H3 in the Hoxa9 locus
We and others have separately demonstrated that the menin and
MLL complex [13,14] and the SUZ12-EZH2 (polycomb proteins)
[27] interact with Hoxa9 regulatory regions. MLL confers histone
H3 lysine 4 (H3K4) methlyation, while SUZ12-EZH2 mediates
Figure 1. Location of H3K4M3 correlated with Hoxa9 expression
level. (A) Diagram of 59 Hoxa cluster genes, from Hoxa5 to Hoxa11,
showing the location of the amplicons used for quantitative Chromatin
Immunoprecipiation assay (qChIP). The enrichment of H3K4 methyla-
tion was determined by qChIP in AT1 cells (B), AR1 cells (C) and MEF26
cells (D). (E) Hoxa9 expression levels in the indicated cell lines as
determined by qPCR. The relative expression level of Hoxa9 gene was
calculated relative to that in MEF26 cells.
doi:10.1371/journal.pone.0000047.g001
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modifications are distributed among positive and negative
elements in the Hoxa9 locus is poorly understood. Having
identified the potentially active and repressive element, we used
quantitative chromatin immunoprecipitation (qChIP) to map
a variety of histone modifications in the Hoxa9 locus, as
represented by amplicons 1–4 (Fig. 1A) in three different cell
lines, each expressing a distinct level of Hoxa9 (Fig. 1E).
The patterns of H3K4 methylation across the regulatory region
of Hoxa9 are distinct among the three cell lines (Fig. 1B to D). In
AT1 cells, which express a medium level of Hoxa9 among the three
cell lines, there were marked enrichments of multiple histone
modification markers including H3K4 trimethylation (H3K4M3),
H3K4 dimethylation (H3K4M2) and H3K4 monomethylation
(H3K4M1) that peaked at amplicon 2 and extended across
amplicons 1, 3 and 4. The enriched level of H3K4M3, H3K4M2
and H3K4M1 accounted for 4–9%, 2–4% and 6–13% of the input
among the four regions, respectively (Fig. 1B). In contrast,
a different pattern of H3K4 modifications was detected in AR1
cells, which express a much higher level of Hoxa9, 41 fold higher
than in AT1 cells (Fig. 1E). Although the level of H3K4M3 at
amplicons 3 and 4 was comparable to that in AT1 cells, it
gradually increased toward 59 amplicons 1–2, culminating at
amplicon 1 to 28% of the input in AR1 cells, as compared to 6.5%
in AT1 cells (Fig. 1C). On the other hand, H3K4M1 and
H3K4M2 in AR1 cells were either quite low or barely detectable.
To compare our results of histone modifications with previously
published data with MEFs [24,29], we also measured H3K4
modifications among the 4 amplicions in MEFs which express
a low level of Hoxa9 (Fig. 1E). In contrast to AR1 cells, no H3K4
methylations were detected at amplicon 1, while H3K4M3 was
gradually increased from 6% to 14% from amplicons 2 to 4.
Enrichment of H3K4M1 and H3K4M2 mimicked the trend of
H3K4M3, albeit at a relatively lower level. Although H3K4
methylations in MEF26 cells were maintained at a relatively high
level at amplicon 4, the expression of Hoxa9 gene was low (Fig. 1E).
These results demonstrate that H3K4 trimethylation at the 59
sequence examined in the Hoxa9 locus is closely correlated with
a high level of Hoxa9 expression, suggesting the importance of the
location of methylated H3K4 in upregulating Hoxa9 expression.
Active and repressive histone modifications coexist
in the Hoxa9 regulatory region
It has been reported that H3K4M2 and H3K4M3, and acetyla-
tion of histone 4 lysine 16 (H4K16Ace) are correlated with
transcriptionally active genes, whereas H3K4M1, dimethylation of
histone 3 lysine 9 (H3K9M2) and dimethylation of histone 3 lysine
27 (H3K27M2) are associated with transcriptional silencing [30–
32]. Although methylation of histone H3K4, H3K9 and H3K27
are important for maintenance of normal Hoxa9 expression
[27,28,33,34] whether these positive and repressive histone modifi-
cations co-exist in Hoxa9 regulation is unclear.
As noticed in AT1 cells, both active (H3K4M2, H3K4M3 and
H4K16Ace) and repressive (H3K4M1, H3K9M2 and H3K27M2)
histone modification markers were differentially enriched at the 59
promoter region (amplicon 2) (Fig. 2A). In contrast, in AR1 cells
H3K4M3 was highly increased but other modifications were
suppressed (Fig. 2B). Similar to AT1 cells, MEF26 cells possessed
both active and repressive histone modifications at both amplicons
2 and 4 (Fig. 2C, D). Enrichment of both active and repressive
chromatin at the same region suggests that they may antagonize or
cooperate to establish a dynamic balance. This balance could be
useful for maintaining the level of Hoxa9 expression. An alteration
in this balance could result in deregulation of Hoxa9 expression.
This is consistent with hyperexpression of Hoxa9 in AR1 cells in
which the repressive histone modifications in the Hoxa9 locus
markedly reduced (Fig. 1C, 1E and 2B). It is likely that the co-
enrichment of repressive histones moderates the high expression of
Hoxa9.
Menin is required for active and repressive histone
H3 modifications in the Hoxa9 locus and the
expression of 59 Hoxa cluster genes
To evaluate the role of menin in histone modifications at various
locations of the Hoxa9 locus, we treated AT1 cells with either
control DMSO or 4-OH tamoxifen (4OHT) to excise floxed Men1,
followed by qChIP assay. 4OHT markedly reduced menin
expression (Fig. 3D). In menin-expressing AT1 cells, H3K4M3
associated with each of the 4 amplicons, reaching 6.5–9% of the
input at amplicons 1–2 (Fig. 3A, right panel). Other histone
modifications, H3K4M2 and H4K16Ace, were also detectable at
amplicons 1–4, albeit at a lower level (Fig. 3A, right panel). In
contrast, Men1 excision (Men1
D/D) markedly reduced all three
active histone modifications (Fig. 3A, right panel). This result is in
agreement with the previous observation that menin facilitates
trimethylation of H3K4, activates Hoxa9 expression [13], and also
links menin’s function to H4K16Ace. Notably, Men1 excision also
markedly reduced all three repressive histone modifications at the
4 amplicons of the Hoxa9 locus (Fig. 3B).
To verify the functional links between menin-associated histone
3 modifications and Hox gene expression, we conditionally excised
menin in AT1 cells and examined menin’s influence on the
expression of 59 Hoxa cluster. In keeping with reported results that
Hoxa5 –a10 are co-expressed in MLL-AF9 transformed cells
[14,18,23], menin excision significantly reduced the expression of
Hoxa9 (7 fold), Hoxa7 (5 fold), Hoxa5 (2 fold) and Hoxa10 (3 fold)
(Fig. 3C). These results suggest that menin is required to maintain
the expression of 59 Hoxa cluster genes in hematopoietic cells
through mediating multiple methylations at histone 3.
Cdx4 is required to regulate the expression of 59
Hoxa cluster genes at a certain stage of
hematopoiesis
Previous studies have shown that menin and Cdx4 induce
hematopoiesis at least in part through regulating Hox genes,
especially Hoxa9 [13,16]. In agreement with the finding that Cdx4
is required for Hoxa9 and Hoxa7 expression [16], our retrovirus-
based Cdx4 shRNAs experiments showed that Cdx4 knockdown
decreased the expression of 59Hoxa cluster genes, Hoxa5- a10;
particularly Hoxa9 expression was reduced by 38 fold relative to
the control (data not shown). These data suggested that the Cdx4
gene is crucial for 59Hoxa cluster expression in AT1 cells, and
especially for Hoxa9 regulation. As Cdx4 is almost absent in AR1
cells (Fig. 4A), we infected AT1 and AR1 cells by Cdx4-expressing
retrovirus. The same vector containing IRES-GFP but not Cdx4
cDNA was used as control. We noticed that ectopic expression of
Cdx4 increased the expression of Hoxa cluster genes 2 fold in AT1
cells (Fig. 4B) but did not change the expression of these genes in
AR1 cells (Fig. 4C). Menin expression was not influenced by
expression level of Cdx4 in both AT1 cells and AR1 cells (Fig. 4 B,
C). Given that AT1 cells express a lower level of Hoxa genes and
have the potential to differentiate into myelomonocytes and
myeloneutrophils (S Fig. 1C), we concluded that Cdx4 gene may
be temporarily required to establish and modulate Hox gene
expression at specific stages of hematopoiesis, possibly during
Cdx4 and Menin Co-Regulation
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required once Hoxa cluster genes have been highly activated in
cells such as AR1 cells. Consistent with this notion, in AR1 cells
Hoxa9 expression was 41 fold higher than that in AT1 cells but
Cdx4 expression was almost absent (Fig. 4A).
Cdx4 and Menin co-regulate expression of the
reporter activity driven by Hoxa9 cis-elements
We further determined whether Cdx4 cooperates with menin in
Hox expression. To this end, we used Hoxa9 gene as a model to
evaluate the effect of menin and Cdx4 on reporter gene activity
(Fig. 5A). We cotransfected four reporters (pB, pD, pE and pF)
containing different Hoxa9 regulatory elements with menin and/or
Cdx4-expressing constructs into 293 cells. As shown in Fig.5B,
when reporter pB was cotransfected with Cdx4 and/or menin, its
activity was induced by Cdx4 and enhanced by co-expressed
menin (Fig. 5B). Neither menin nor Cdx4 alone had significant
effects on reporters pD and pF (Fig. 5B). Interestingly, cotransfect-
ing both menin and Cdx4 with reporter pE yielded an additive
activation of the reporter expression by 3.5 fold higher than either
menin (1.3 fold) or Cdx4 (2.5 fold) alone (Fig. 5B). Thus, the luci-
Figure 2. Active and repressive histone modification markers were co-enriched in Hoxa9 locus. Active histone markers including H4K16Ace,
H3K4M2 and H3K4M3, were indicated as grey bars. Repressive markers including H3K4M1, H3K9M2 and H3K27M2 were indicated as black bars. (A)
AT1 cells maintain both active and repressive histone modifications at amplicon 2. (B) AR1 cells show aberrant high expression of active histone
modifications but low level of repressive histone modifications at amplicon 2. (C) and (D) show that MEF26 cells contain both active and repressive
histone markers at amplicons 2 and 4, respectively.
doi:10.1371/journal.pone.0000047.g002
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of the Hoxa9 elements, and menin may enhance its activation.
Cdx4 protein specifically binds to two sites in the
Hoxa9 regulatory region in vitro
To determine whether Cdx4 directly interacts with Hoxa9
regulatory elements, we performed sequence homolog search for
the consensus binding sites (TTTATA/G) for Cdx4 [36]. The
search revealed three Cdx4 binding sites (CBS): one in the 59 part
of element B and the other two closely located within element E
(Fig. 6A and B). We then performed gelshift assays to establish
whether Cdx4 can bind these sites. Of six wild type oligonucleotide
sequences used as probes (see material and methods), only two
probes (probe 2 and 6) were specifically bound by in vitro
synthesized Cdx4 protein (A.S. data not shown). We then focused
on these two probes. Both probes 2 and 6 bound the in vitro
translated Cdx4 (Fig. 6C, lanes 3 and 17), but not the control
lysate (lanes 2 and 16). Moreover, Cdx4/probe 2 complex was
abolished by incubation with an anti-Cdx4 antibody but not by
control IgG (lanes 4 and 6), in agreement with the previous report
[36], suggesting that Cdx4/probe 2 interaction or stability of the
Figure 3. Menin is required for both active and repressive histone modifications in AT1 cells. Menin excision (Men1
D/D) dramatically reduced active
(A) and repressive (B) histone modifications. The highly enriched peak of H3K4M3 and H3K4M2 were almost completely abrogated. (C) Menin excision
also reduced the expressions of Hoxa5, Hoxa7, Hoxa9 and Hoxa10. No expression of Hoxa1 and Hoxa13 was detectable. (D) 4-OH Tamoxifen (4-OHT)
treatment substantially reduced menin expression as compared to non-tamoxifen treated AT1 cells. Mouse b-actin was used as control.
doi:10.1371/journal.pone.0000047.g003
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6 complex was further supershifted by the same anti-Cdx4 anti-
body, but not by the control IgG (Fig. 6C, lanes 18 and 20). Since
probe 6 contains two CBS tandem repeats with surrounding
nucleotide sequences different from probe 2, probe 6 might form
a more stable complex with Cdx4 protein. Similar to most homeo-
domain proteins, Cdx4 possibly forms a dimer to bind to target
DNA [37–39]. Thus, two tandem sites may stabilize the Cdx4/
DNA interaction, resulting in supershift of Cdx4/DNA complex.
To further evaluate the specificity of Cdx4 and probes 2 and 6
interaction, we introduced three nucleotide substitutions into the
CBSs in each probe (Fig. 6B), and each of the mutated probes
failed to bind Cdx4 (Fig. 6C, lanes 8–14, and 22–28). This series of
experiments indicate that Cdx4 interacts in vitro with CBSs from
element B and E (Fig. 5A), which confers Cdx4 direct upregulation
to reporter expression.
Menin modulates Cdx4 access to the chromatin
targets in Hoxa9 locus
To determine whether Cdx4 associates with the Hoxa9 locus in vivo,
we performed qChIP assays. We found that menin and Cdx4 co-
localized to the 59 promoter region, and particularly enriched
a region represented by amplicon 2 (Fig. 7A). Menin ablation
abolished Cdx4-chromatin binding, while menin binding to the
region was also markedly reduced due to menin excision from the
cells (Fig.7A). Agarose electrophoresis of PCR products confirmed
that the appropriate target was amplified (Fig. 7B). Unexpectedly,
amplicon 4, which contains two CBSs was not as efficiently bound
by Cdx4 as amplicon 2 (Fig. 7A). Thus, Cdx4 binding to the
chromatin target depends on accessibility of the targets, and menin
facilitates association of Cdx4 with the Hoxa9 locus.
DISCUSSION
Hox genes play an essential role in controlling normal hematopoi-
esis as well as leukemogenesis [1,40]. The expression of Hox gene is
tightly regulated during the process of hematopoietic proliferation
and differentiation. For example, Hoxa9 and Hoxa7 are expressed in
primitive progenitors and downregulated at the time of differen-
tiation [40–42]. Histone modifications provide a dynamic and
versatile code for the recruitment of factors that control gene
transcription [43]. We are the first to have demonstrated that
Figure 5. Cdx4 and menin co-regulate the reporter activity driven by
Hoxa9 regulatory elements. (A) Diagram of Hoxa9 locus, showing the
locations of amplicons and the corresponding reporter elements B, D, E
and F. (B) Co-expression of menin and Cdx4 with reporters in 293 cells
induced the activity of reporters pB and pE. The reporter activity was
arbitrarily calculated relative to vector control. (C) Western blot shows
that in vitro synthesized and transiently expressed Cdx4 was specifically
detected by anti-Cdx4 antibodies.
doi:10.1371/journal.pone.0000047.g005
Figure 4. Cdx4 is crucial for the expression of 59 Hoxa cluster genes in
hematopoietic AT1 cells. (A) Expression profile of Men1, MLL, Cdx4 and
Hoxa9 was determined by quantitative real time RT-PCR. Ectopic
expression of Cdx4 increased the expression of 59 Hoxa cluster in AT1
cells (B) but not in AR1 cells (C).
doi:10.1371/journal.pone.0000047.g004
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to regulate Hoxa9 expression. Thus, our results reveal two distinct
yet related mechanisms in regulating Hoxa9 expression in
hematopoietic cells: Cdx4 binding to the CBSs and menin-
dependent multiple H3K4 methylations at the Hoxa9 locus.
Menin-dependent H3K4 methylation is closely
correlated with expression of the 59 Hoxa cluster in
MLL-AF9 transformed cells
Modern tumor biology has emphasized a quantitative model by
which cells undergo gradual ‘progressive’ alterations, taking them
from normal phenotype to abnormal (precancer) and to malignant
phenotype (cancer) [44,45]. To this end, we applied a quantitative
strategy to link the expression level of Hox genes with the
enrichment of specific histone methylations in Hoxa9 regulatory
region. This was performed in several cell lines with distinct levels
of Hoxa9 expression in decreasing magnitude: AR1, AT1, and
MEF26 cells. In correlation with an increase of Hoxa9 expression,
an enriched peak of H3K4M3 was shifted from 39 to 59 of the
Hoxa9 regulatory sequence from MEF26 to AR1 (Fig. 1).
Trimethylated H3K4 has been reported to associate primarily
with the promoter regions of actively expressed genes [46,47] and
extended across the Hoxa9 locus in MLL-fusion transformed cells
Figure 6. In vitro detection of Cdx4 protein binding sites in the regulatory region of Hoxa9. (A) A diagram of Hoxa9 locus, showing the
corresponding locations between amplicons for qChIPs, reporter elements for luciferase analysis and oligo probes for EMSA. (B) The wild-type and
mutation sequences of probe 2 (left) and probe 6 (right). The Cdx protein consensus binding sites were underlined. Wild type sequence of Probe 2
contains onepotentialCdx consensus bindingsite (CBSs) whileprobe6 containstwo tandemCBSs. (C) Cdx4proteinwas able to bind probe2 wild type
sequence but not the mutant sequence. Asterisk (*) denotes a band that likely resulted from partially degraded Cdx4. Their binding was inhibited by
anti-Cdx4 antibody but not by a control IgG (left panel). The same in vitro binding assay was conducted for probe 6 and its mutant (right panel).
doi:10.1371/journal.pone.0000047.g006
Cdx4 and Menin Co-Regulation
PLoS ONE | www.plosone.org 7 December 2006 | Issue 1 | e47[46,48]. Moreover, our data suggest that the extension of
trimethylated H3K4 towards the 59 Hoxa9 regulatory region is
closely correlated with increasing expression of Hoxa9. It is possible
that H3K4M3 in the 59 part of the locus is more efficient in
recruiting cofactors, such as chd1 which activates gene transcrip-
tion by chromatin remodeling to stimulate gene transcription
[9,13,49,50]. Further studies are required to clarify this possibility.
Despite loss of the SET domain in MLL fusion proteins, they can
actively increase binding of the endogenous and intact MLL to the
target genes 5 to 15 fold, leading to increased H3K4 trimethyla-
tion [48]. Thus, one way that menin regulates expression of Hoxa9
and other Hoxa cluster genes may be to modulate the recruitment
of endogenous MLL and MLL-AF9 to a particular locus to alter
histone modifications.
Detection of the co-existence of active and repressive histone
modifications at the Hoxa9 locus is consistent with the notion that
certain genes controlling cell ‘‘stemness’’ or plurotency are
coordinately regulated by active and repressive chromatin
modifications [46,51]. Alternations of this co-existence may also
influence the expression level of Hoxa9. For instance, in AT1 cells
and MEF26 cells both active and repressive histone modification
markers were enriched whereas, repressive histone modifications
were significantly diminished in AR1 cells that express a high level
of Hoxa9.
Wefurtherdemonstratedthatmeninisacrucialregulatorforboth
active and repressive histone 3 modifications in the Hoxa9 locus.
Ablation of menin almost abolished both active and repressive
histone modifications and reduced expression of 59Hoxa cluster
genes, Hoxa5 to a10 in AT1 cells. Menin associates with MLL and
the Hoxa9 locus [13,14,29,52]. Moreover, our new findings suggest
the possibility that menin may play a role in the communication
between activator and repressor factors in Hox gene regulation.
Further studies are needed to decipher this function.
Cdx4 binds the Hoxa9 locus and is required for Hoxa
9 expression in normal hematopoietic cells
Cdx4 is required for normal hematopoiesis, stem cell function, and
Hoxa9 expression in both mice and Zebrafish [16,35]. Enforcing its
crucial role, a point mutation of Zebrafish Cdx4 homolog
abrogates normal hematopoiesis and Hoxa9 transcription, while
ectopic expression of Hoxa9 can partially rescue the defect [16].
However, it remains unclear whether Cdx4 directly binds any of
Hox genes’ loci to regulate their transcription. We have now shown
that Cdx4 directly binds to the CBSs in the 59 portion of the Hoxa9
locus, both in vitro and in vivo. Significantly, knockdown of Cdx4 led
to marked reduction of multiple 59 Hoxa cluster genes, including
Hoxa9 in AT1 cells (Fig. 4B), whereas ectopic expression of Cdx4
upregulates expression of multiple endogenous Hoxa cluster genes
including Hoxa9. These results indicate an essential role for Cdx4
in promoting expression of endogenous Hoxa genes. Further
supporting these observations, Cdx4 upregulates expression of the
reporter driven by the Hoxa9 elements containing CBSs, but not
the reporter driven by elements without CBSs (Fig. 5). Together,
these results indicate that Cdx4 can directly bind the Hoxa9 locus
to promote transcription of Hoxa9, uncovering a direct link
between Cdx4 and expression of Hox genes.
Cdx4 and menin co-regulate the expression of 5
Hoxa cluster genes
We have shown that Cdx4 and menin bound to the same region in
the Hoxa9 locus, and they also additively activate the cis-element
from the locus. Importantly, loss of menin prevents Cdx4 targeting
the Hoxa9 gene. The precise nature of the interaction among
menin, Cdx4 and chromatin DNA targets is not yet clear, but
could involve the menin-MLL complex, which is known to
mediate H3K4 methylation. However, we do not have evidence
that Cdx4 directly interacts with menin in co-immunoprecipitation
assay (A.S., data not shown). Histone modifications can directly
affect chromatin structure and present a special surface for
interaction with other proteins, resulting in either activation or
repression of gene transcription [43]. Although Cdx4 possesses
intrinsic ability to bind the CBSs, Cdx4 itself is not sufficient to
initiate Hoxa9 expression in the embryonic stem cells (data not
shown). Menin-dependent histone modifications via MLL in the
Hoxa9 locus may further recruit/stabilize Cdx4 in the chromatin
and thus, establish an optimal level of Hoxa cluster gene
expression at certain developmental stage of hematopoietic cells,
such as AT1 cells. Obviously, menin is an essential oncogenic
cofactor to regulate Hoxa9 expression in MLL-associated leuke-
mogenesis [14] whereas Cdx4 is no longer required to maintain
a high level of Hox gene expression in AR1 cells (Fig. 4B, 4D).
Thus, Cdx4 may function as a temporal regulator in establishment
and/or modulation of Hox expression. Indeed, Cdx proteins have
long been recognized as playing an important role in the initiation
of Hox gene expression [26] in a dosage-dependent mode [53].
Aberrant histone modifications are implicated in
MLL-associated leukemogensis
MLL-AF9 promotes expansion of myeloid precursors, Hox gene
dysregulation and the eventual development of myeloid leukemia
[4,23,54]. Transformation of MLL-AF9 fusion gene into mouse
Figure 7. Loss of menin abolishes Cdx4 binding to chromatin targets.
(A) qChIP assay shows that Cdx4 and menin have a similar binding peak
at amplicon 2. Menin excision (AT1 Men1
D/D) almost completely blocked
Cdx4 binding. (B) The amplified PCR product for amplicon 2 was
separated on 1.5% agarose gel.
doi:10.1371/journal.pone.0000047.g007
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precursors is the first stage of MLL-AF9-mediated leukemia
followed by accumulation of malignant cells in bone marrow and
other tissue [4]. The long latency in vivo and monoclonal nature of
the leukemias suggest that the secondary genetic alterations are
required [4,55,56]. Here, we provided additional evidence that
dysregulation of 59 Hoxa cluster is closely correlated with aberrant
histone H3 modifications in Hoxa9 locus. In AR1 cells the
expression of Hoxa5, a7 and a9 was increased 20 to 40 fold higher
than in AT1 cells, and in particular, Hoxa10 expression was
increased by 105 fold. In parallel with the dysregulation of 59Hoxa
cluster genes from a5 to a10, an enriched peak of trimethylated
H3K4 was shifted from the 39 to 59 direction of the Hoxa9
regulatory sequence, and repressive histone modifications were
suppressed in aggressive AR1 cells as compared to AT1 cells
(Fig.1). Our data suggest that the ‘‘progressive’’ epigenetic
alterations occurred from AT1 to AR1 possibly contribute to the
secondary mutations that are required for the development of
leukemia in the MLL-AF9 murine model system [4,22]. Taken
together, our studies suggest a coordinated role for Cdx4 and the
menin-MLL complex in modulating Hoxa9 expression during
MLL-associated myeloid transformations, while Cdx4 is no longer
required in full-blown leukemia cells such as AR1 cells.
Comparison of sequences in UniGene with Cdx4 and menin
proteins between mouse and human complete genome indicates
that these proteins are highly conserved with amino acid identity
of 82.39% in Cdx4 and 95.78% in menin. The DNA sequence
covering regulatory elements B to F at Mouse Hoxa9 locus (Fig. 5A)
possess 71% to 96% of DNA sequence identity to human Hoxa9
locus. The identities of the element B and element E which contain
Cdx4 binding sites are 77% and 92%, respectively. Therefore, our
studies have significant biological implications in further decipher-
ing the detailed mechanisms whereby Hox genes are regulated to
control hematopoiesis and leukemogenesis as well as devising
novel therapeutic interventions by targeting the menin pathway in
humans.
MATERIALS AND METHODS
Cell lines and cell culture
The AT1 cell line was generated from the murine bone marrow
cells of Men1
l/l, Cre-ER mice by introduction with retrovirus
expressing MLL-AF9 fusion protein, as we previously described
[13]. Similarly, the other MLL-AF9 cell line (AR1) was generated
by transducing MLL-AF9 fusion protein into the bone marrow
cells of Men1
l/l mice. AT1 cells and AR1 cells were cultured in
modified IMDM [Iscove’s Modified Dulbecco’s medium (Stem-
Cell Technologies Inc, Vancouver, BC) containing 200 mM non-
essential amino acids, 200 mM L-glutamine, 10 U/ml penicillin
and 10 mg/ml Streptomycin supplemented with 15% fetal bovine
serum (FBS) (Harlan Bioproducts for Science, Indianapolis, IN)
and IL3].
Retroviral constructs and infection
Retroviral MSCV-Cdx4-ires-GFP and MSCV-ires-GFP vectors
were kindly provided by George Daley [16]. The viruses were
packaged to infect AT1 cells and AR1 cells as previously described
[13]. The retrovirally transduced cells by MSCV-Cdx4-GFP and
MSCV-GFP virus were highly purified on the expression of GFP
using MoFlo Cell Sorter (Dako Cytomation).
Quantitative Gene Expression Analysis
Total RNA was prepared with Trizol reagent, and cDNA was
synthesized with random hexamers and Superscript II (Invitro-
gen). Taqman PCR reactions were performed with 1–2 mlo f
cDNA on a 7500 Fast Real-Time PCR System (Applied
Biosystems) following the manufacturer’s instructions. Primers
and probes labeled at the 59 end with FAM (MGB TaqMan Probe)
were listed in the Supporting Information, Data S2. GAPDH
(Mm99999915) and/or b-actin (Mm00607939) were used as
internal controls for normalization. Data was analyzed using the
comparative CT method following the manual described (Applied
Biosystem). The average CT value from three independent assays
was listed in the Supporting Information, Data S2.
Luciferase assays
DNA fragments (regulatory elements) from the promoter and 59
UTR regions were obtained by PCR using mouse tail genomic
DNA as the template and cloned into the pGL3-basic vector
(Promega) at Kpn-BglII restriction sites. All constructs were
validated by restriction digestions and sequencing analyses. Co-
transfections of 500 ng luciferase reporters (pA, pB, pC, pD, pE,
pF or pGL3 empty vector) and 1 mg of expression vectors were
performed in 12 well plates using Lipofectamine 2000 (Invitrogen)
with 50 ng of pTK-Renilla (Promega) as an internal control. The
luciferase activities were measured on TR717 Microplate
Luminometer (Tropix, PE Applied Biosystem) using the Dual-
luciferase assay kit (Promega). The following expression vectors
were utilized: pSG5-Cdx4 and pcDNA3-Menin, which were
generated by inserting the mouse Cdx4 cDNA into pSG5 [36]
and the human menin cDNA into pcDNA3 [57] respectively. The
empty pcDNA3 was used as a vector control to normalize the total
DNA for transfection.
Chromatin Immunoprecipitation (ChIP) analysis
Chromatin immunoprecipitation assays were performed using the
Chromatin Immunoprecipitation Assay Kit (Upstate, Lake Pacid,
NY) and specific antibodies (See Supporting Information S1). As
control for ChIP assays and for antibody specificity, equal amounts
(5 mg) of IgG and antibodies were used in parallel reactions. Using
Taqman Real-time PCR (RT-PCR), the immunoprecipitated
DNA samples were quantified relative to input DNA and
calculated based on the formula: % totalsample=[2
(DCTinput2DCT-
sample)6% totalinput] [58]. To reduce background, DCT value is
determined by subtracting the average CTIgG value from the
average CTinput value or CTsample value. Primer and probe
sequences were included in Supporting Information, Data S2.
Electrophoretic mobility shift assay (EMSA)
EMSA was carried out as previously described [36] with the
following modifications. The coding region of Cdx4 was amplified
from the pSG5-Cdx4 vector using primers (Cdx4F2, cacc gtc acc
atg tat gga atc tgc and Cdx4R2, ttc aga aac tat gac ctg ctg tat c).
The PCR product was cloned into the pCR4-TOPO vector
(Invitrogen). The resultant plasmid, pCR4-Cdx4, was sequenced
and restriction digested to determine its insert orientation. The
TnT3 Quick coupled transcription-translation system (Promega)
was used to produce Cdx4 protein in vitro, while the TnT7 Quick
coupled transcription-translation system (Promega) was used to
produce Cdx4-R as a control from the same plasmid (pCR4-
Cdx4). The in vitro translated products were immunoblotted with
anti-Cdx4 antibody. Six wild type sequences of double-stranded
end-labeled oliogonucleotides covering the following regions were
tested for Cdx4 and Cdx4-R protein binding by EMSA: probe1,
probe 2 and probe 3 located within element B, probe 4 and probe
5 within element D and probe 6 within element E.
Cdx4 and Menin Co-Regulation
PLoS ONE | www.plosone.org 9 December 2006 | Issue 1 | e47Western blotting
Whole-cell extracts were prepared followed by protein concentra-
tion determination. Equivalent amounts of protein from each
sample were then subjected to SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE) on a 10% gel, transferred to nitrocellulose,




Found at: doi:10.1371/journal.pone.0000047.s001 (0.03 MB
DOC)
Data S2
Found at: doi:10.1371/journal.pone.0000047.s002 (0.06 MB
DOC)
Figure S1 Characterization of AT1 and AR1 cells. (A) AT1 and
AR1 cells were seeded in 6-well plate in triplicate, 16105 cells in
each well. AR1 cells grow much faster than AT1 cells. (B) The
expression profile of 59Hoxa cluster genes in AT1 and AR1 cells
was determined by quantitative real time RT-PCR analysis.
Relative to AT1 cells, AR1 cells expressed significantly higher
expression of Hoxa5, a7, a9 and a10, especially Hoxa10 with 105
fold of increase. (C) AT1 cells were predominately myeloblast
morphology with a mixed population of a few differentiated
myelomonocytes and myeloneutrophils, whereas, AR1 cells
retained immature myelobalsts. Cells were stained with Giemsa
and observed under light microscopy (Leisca, original magnifica-
tion, 640). Myeloblasts were morphologically defined by their
large size, granular appearance and high nucleus-cytoplasm ratio
[4,23].
Found at: doi:10.1371/journal.pone.0000047.s003 (12.81 MB
TIF)
Figure S2 Identification of functional cis-elements at Hoxa9
regulatory region. (A) Diagram of Hoxa9 locus, showing locations
of regulatory elements for luciferase assays. The regulatory
elements were cloned into pGL3-basic vector to generate various
reporter genes. (B) Luciferase assays were conducted in menin-
expressing MEF26 cells. The luciferase activity was calculated
relative to the empty vector control (pGL3-basic).
Found at: doi:10.1371/journal.pone.0000047.s004 (4.74 MB TIF)
ACKNOWLEDGMENTS
We are indebted to Shawn Burgess, Paul Liu, Zengfeng Wang and Martine
Behra for critical reading of the manuscript. We thank all the other
members of the Hua lab for stimulating discussions. We also thank
Jacqueline Deschamps (Netherlands Institute for Developmental Biology,
the Netherlands) for providing Cdx plasmids; George Daley for providing
MSCV-Cdx4-ires-GFP and MSCV-ires-GFP vectors; and William DeMuth
for FACS sorting GFP expressing cells. We acknowledge Douglas Lin,
AFCRI’s Diehl lab, for his expertise in shRNA technique.
Author Contributions
Conceived and designed the experiments: XH JY. Performed the
experiments: JY YC AD AS YY. Analyzed the data: XH JY YC.
Contributed reagents/materials/analysis tools: HW. Wrote the paper: XH
JY.
REFERENCES
1. Magli MC, Largman C, Lawrence HJ (1997) Effects of HOX homeobox genes
in blood cell differentiation. J Cell Physiol 173: 168–177.
2. Owens BM, Hawley RG (2002) HOX and non-HOX homeobox genes in
leukemic hematopoiesis. Stem Cells 20: 364–379.
3. Ayton PM, Cleary ML (2001) Molecular mechanisms of leukemogenesis
mediated by MLL fusion proteins. Oncogene 20: 5695–5707.
4. Dobson CL, Warren AJ, Pannell R, Forster A, Lavenir I, et al. (1999) The mll-
AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid
leukaemogenesis. Embo J 18: 3564–3574.
5. Look AT (1997) Oncogenic transcription factors in the human acute leukemias.
Science 278: 1059–1064.
6. Sorensen PH, Chen CS, Smith FO, Arthur DC, Domer PH, et al. (1994)
Molecular rearrangements of the MLL gene are present in most cases of infant
acute myeloid leukemia and are strongly correlated with monocytic or
myelomonocytic phenotypes. J Clin Invest 93: 429–437.
7. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, et al.
(1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1.
Science 276: 404–407.
8. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, et al. (1997)
Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The
European Consortium on MEN1. Hum Mol Genet 6: 1177–1183.
9. Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, et al.
(2004) Menin associates with a trithorax family histone methyltransferase
complex and with the hoxc8 locus. Mol Cell 13: 587–597.
10. Lemmens IH, Forsberg L, Pannett AA, Meyen E, Piehl F, et al. (2001) Menin
interacts directly with the homeobox-containing protein Pem. Biochem Biophys
Res Commun 286: 426–431.
11. Lin SY, Elledge SJ (2003) Multiple tumor suppressor pathways negatively
regulate telomerase. Cell 113: 881–889.
12. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, et al. (2004) Leukemia
proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex
with menin to regulate Hox gene expression. Mol Cell Biol 24: 5639–5649.
13. Chen YX, Yan J, Keeshan K, Tubbs AT, Wang H, et al. (2006) The tumor
suppressor menin regulates hematopoiesis and myeloid transformation by
influencing Hox gene expression. Proc Natl Acad Sci U S A 103: 1018–1023.
14. Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, et
al. (2005) The Menin Tumor Suppressor Protein Is an Essential Oncogenic
Cofactor for MLL-Associated Leukemogenesis. Cell 123: 207–218.
15. Pollard SL, Holland PW (2000) Evidence for 14 homeobox gene clusters in
human genome ancestry. Curr Biol 10: 1059–1062.
16. Davidson AJ, Ernst P, Wang Y, Dekens MP, Kingsley PD, et al. (2003) cdx4
mutants fail to specify blood progenitors and can be rescued by multiple hox
genes. Nature 425: 300–306.
17. Lawrence HJ, Christensen J, Fong S, Hu YL, Weissman I, et al. (2005) Loss of
expression of the Hoxa-9 homeobox gene impairs the proliferation and
repopulating ability of hematopoietic stem cells. Blood 106: 3988–3994.
18. Ayton PM, Cleary ML (2003) Transformation of myeloid progenitors by
MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 17:
2298–2307.
19. Calvo KR, Sykes DB, Pasillas M, Kamps MP (2000) Hoxa9 immortalizes
a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte
capable of biphenotypic differentiation to neutrophils or macrophages, in-
dependent of enforced meis expression. Mol Cell Biol 20: 3274–3285.
20. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999)
Molecular classification of cancer: class discovery and class prediction by gene
expression monitoring. Science 286: 531–537.
21. Nakamura T, Largaespada DA, Shaughnessy JD Jr., Jenkins NA, Copeland NG
(1996) Cooperative activation of Hoxa and Pbx1-related genes in murine
myeloid leukaemias. Nat Genet 12: 149–153.
22. Johnson JJ, Chen W, Hudson W, Yao Q, Taylor M, et al. (2003) Prenatal and
postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of
MLL fusion gene leukemia. Blood 101: 3229–3235.
23. Kumar AR, Hudson WA, Chen W, Nishiuchi R, Yao Q, et al. (2004) Hoxa9
influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia.
Blood 103: 1823–1828.
24. Dou Y, Milne TA, Tackett AJ, Smith ER, Fukuda A, et al. (2005) Physical
association and coordinate function of the H3 K4 methyltransferase MLL1 and
the H4 K16 acetyltransferase MOF. Cell 121: 873–885.
25. Schnepp RW, Hou Z, Wang H, Petersen C, Silva A, et al. (2004) Functional
interaction between tumor suppressor menin and activator of S-phase kinase.
Cancer Res 64: 6791–6796.
26. Deschamps J, van Nes J (2005) Developmental regulation of the Hox
genes during axial morphogenesis in the mouse. Development 132:
2931–2942.
27. Cao R, Zhang Y (2004) SUZ12 is required for both the histone methyltransfer-
ase activity and the silencing function of the EED-EZH2 complex. Mol Cell 15:
57–67.
28. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, et al. (2002) Role of
histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298:
1039–1043.
Cdx4 and Menin Co-Regulation
PLoS ONE | www.plosone.org 10 December 2006 | Issue 1 | e4729. Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, et al. (2002) MLL
targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell
10: 1107–1117.
30. Dehe PM, Pamblanco M, Luciano P, Lebrun R, Moinier D, et al. (2005)
Histone H3 lysine 4 mono-methylation does not require ubiquitination of
histone H2B. J Mol Biol 353: 477–484.
31. Morillon A, Karabetsou N, Nair A, Mellor J (2005) Dynamic lysine methylation
on histone H3 defines the regulatory phase of gene transcription. Mol Cell 18:
723–734.
32. van Dijk K, Marley KE, Jeong BR, Xu J, Hesson J, et al. (2005) Monomethyl
histone H3 lysine 4 as an epigenetic mark for silenced euchromatin in
Chlamydomonas. Plant Cell 17: 2439–2453.
33. Lachner M, Jenuwein T (2002) The many faces of histone lysine methylation.
Curr Opin Cell Biol 14: 286–298.
34. Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, et al. (2002) ALL-1
is a histone methyltransferase that assembles a supercomplex of proteins involved
in transcriptional regulation. Mol Cell 10: 1119–1128.
35. Wang Y, Yates F, Naveiras O, Ernst P, Daley GQ (2005) Embryonic stem cell-
derived hematopoietic stem cells. Proc Natl Acad Sci U S A 102: 19081–19086.
36. Tabaries S, Lapointe J, Besch T, Carter M, Woollard J, et al. (2005) Cdx protein
interaction with Hoxa5 regulatory sequences contributes to Hoxa5 regional
expression along the axial skeleton. Mol Cell Biol 25: 1389–1401.
37. Gregory PA, Gardner-Stephen DA, Rogers A, Michael MZ, Mackenzie PI
(2006) The caudal-related homeodomain protein Cdx2 and hepatocyte nuclear
factor 1alpha cooperatively regulate the UDP-glucuronosyltransferase 2B7 gene
promoter. Pharmacogenet Genomics 16: 527–536.
38. Mendel DB, Khavari PA, Conley PB, Graves MK, Hansen LP, et al. (1991)
Characterization of a cofactor that regulates dimerization of a mammalian
homeodomain protein. Science 254: 1762–1767.
39. Wilson DS, Guenther B, Desplan C, Kuriyan J (1995) High resolution crystal
structure of a paired (Pax) class cooperative homeodomain dimer on DNA. Cell
82: 709–719.
40. Moore MA (2005) Converging pathways in leukemogenesis and stem cell self-
renewal. Exp Hematol 33: 719–737.
41. Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE (1999)
Expression of HOX genes, HOX cofactors, and MLL in phenotypically and
functionally defined subpopulations of leukemic and normal human hemato-
poietic cells. Leukemia 13: 687–698.
42. Lawrence HJ, Rozenfeld S, Cruz C, Matsukuma K, Kwong A, et al. (1999)
Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human
myeloid leukemias. Leukemia 13: 1993–1999.
43. Berger SL (2002) Histone modifications in transcriptional regulation. Curr Opin
Genet Dev 12: 142–148.
44. Araten DJ, Golde DW, Zhang RH, Thaler HT, Gargiulo L, et al. (2005) A
quantitative measurement of the human somatic mutation rate. Cancer Res 65:
8111–8117.
45. Luzzatto L (2001) The mechanisms of neoplastic transformation. Eur J Cancer
37 Suppl 8: S114–117.
46. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, et al. (2005)
Genomic maps and comparative analysis of histone modifications in human and
mouse. Cell 120: 169–181.
47. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, et al.
(2004) Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat
Cell Biol 6: 73–77.
48. Milne TA, Martin ME, Brock HW, Slany RK, Hess JL (2005) Leukemogenic
MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting
transcription and multiple histone modifications. Cancer Res 65: 11367–11374.
49. Krogan NJ, Kim M, Tong A, Golshani A, Cagney G, et al. (2003) Methylation
of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional
elongation by RNA polymerase II. Mol Cell Biol 23: 4207–4218.
50. Pray-Grant MG, Daniel JA, Schieltz D, Yates JR 3rd, Grant PA (2005) Chd1
chromodomain links histone H3 methylation with SAGA- and SLIK-dependent
acetylation. Nature 433: 434–438.
51. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, et al. (2006) Control
of developmental regulators by Polycomb in human embryonic stem cells. Cell
125: 301–313.
52. Yokoyama A, Kitabayashi I, Ayton PM, Cleary ML, Ohki M (2002) Leukemia
proto-oncoprotein MLL is proteolytically processed into 2 fragments with
opposite transcriptional properties. Blood 100: 3710–3718.
53. Gaunt SJ, Drage D, Trubshaw RC (2005) cdx4/lacZ and cdx2/lacZ protein
gradients formed by decay during gastrulation in the mouse. Int J Dev Biol 49:
901–908.
54. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, et al. (2003) Dimerization
of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 4:
197–207.
55. Lavau C, Du C, Thirman M, Zeleznik-Le N (2000) Chromatin-related
properties of CBP fused to MLL generate a myelodysplastic-like syndrome that
evolves into myeloid leukemia. Embo J 19: 4655–4664.
56. Lavau C, Luo RT, Du C, Thirman MJ (2000) Retrovirus-mediated gene transfer
of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid
leukemias in mice. Proc Natl Acad Sci U S A 97: 10984–10989.
57. Jin S, Mao H, Schnepp RW, Sykes SM, Silva AC, et al. (2003) Menin associates
with FANCD2, a protein involved in repair of DNA damage. Cancer Res 63:
4204–4210.
58. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B (2001) Binding of c-
Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene
activation. Genes Dev 15: 2069–2082.
59. Schnepp RW, Mao H, Sykes SM, Zong WX, Silva A, et al. (2004) Menin
induces apoptosis in murine embryonic fibroblasts. J Biol Chem 279:
10685–10691.
Cdx4 and Menin Co-Regulation
PLoS ONE | www.plosone.org 11 December 2006 | Issue 1 | e47